university website

D. Dodick (David), R.B. Lipton (Richard), V. Martin (Vincent), V. Papademetriou (Vasilios), W.D. Rosamond (Wayne), A. Maassen van den Brink (Antoinette), H. Loutfi (Hassan), K.M. Welch (K. Michael), P.J. Goadsby (P.), S. Hahn (Steven), et al. S. Hutchinson (Susan), D.B. Matchar (David), S. Silberstein (Stephen), T.D. Smith (Timothy), I. Purdy and J. Saiers (Jane)

2004-05-01

Consensus statement: Cardiovascular safety profile of triptans (5-HT 1B/1D agonists) in the acute treatment of migraine

Publication

Publication

Headache: the journal of head and face pain , Volume 44 - Issue 5 p. 414- 425

Additional Metadata
Keywords Consensus statement, Headache, Migraine, Triptans
Persistent URL doi.org/10.1111/j.1526-4610.2004.04078.x, hdl.handle.net/1765/73924
Journal Headache: the journal of head and face pain
Organisation Department of Pharmacology
Citation
Dodick, D., Lipton, R., Martin, V., Papademetriou, V., Rosamond, W., Maassen van den Brink, A., Loutfi, H., Welch, K. M., Goadsby, P., Hahn, S., Hutchinson, S., Matchar, D., Silberstein, S., Smith, T., Purdy, I.& Saiers, J. (2004). Consensus statement: Cardiovascular safety profile of triptans (5-HT 1B/1D agonists) in the acute treatment of migraine. In Headache: the journal of head and face pain (Vol. 44, Number 5, pp. 414–425).https://doi.org/10.1111/j.1526-4610.2004.04078.x


User Publication Person Organisation Collection
Close